Antiplatelet Therapy and Cardiovascular Diseases

This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of cardiovascular events, especially in the context of percutaneous coronary intervention. It also explores the impact of genetic polymorphisms, platelet reactivity, and bleeding risk on the efficacy and safety of antiplatelet drugs.

Journals publishing in this area